Hyperliquid Equity Financing Facility Expands to $2.5 Billion for HYPE Buys

Hyperliquid Strategies has given itself a lot more room to grow its crypto treasury. The Nasdaq-listed company disclosed in a Sept. 1 filing with the U.S. Securities and Exchange Commission that it has expanded its Hyperliquid equity financing facility with Chardan Capital Markets from $1 billion to $2.5 billion, a move that widens its capacity to raise cash for buying more HYPE, the token tied to the Hyperliquid network.

Key takeaways

• The equity financing facility that Hyperliquid Strategies maintains with Chardan Capital Markets was increased to $2.5 billion from $1 billion.
• Through this same facility, the company previously secured $647 million and subsequently deployed $773.4 million toward acquiring approximately 16.5 million HYPE tokens following its December 2025 business combination.
• As of Aug. 19, Hyperliquid Strategies held about 29.3 million HYPE tokens and $149.9 million in cash, with no debt on the books.
• A Nasdaq rule caps share sales below $12.02 apiece without shareholder approval once cumulative sales through the facility hit $1 billion.
• Shares closed at $11.36 on Sept. 1, below that threshold, though the cap only kicks in after the $1 billion sales mark is reached.

Expansion of Hyperliquid’s Equity Financing Facility

The core of this news is simple: Hyperliquid Strategies now has 2.5 times more capacity to raise money through stock sales than it did before. The expanded Hyperliquid equity financing arrangement with Chardan Capital Markets lifts the facility’s ceiling from $1 billion to $2.5 billion, giving the company far more flexibility to fund its treasury strategy without needing a separate capital raise every time it wants to buy more tokens.

Details of the Facility Increase

It’s worth being precise about what this $2.5 billion figure actually means. It represents the maximum size of the facility, not money the company has already collected or committed to spending on HYPE. Hyperliquid Strategies still decides when and how much stock to issue, based on market conditions, its share price, and how leadership wants to deploy the proceeds.

Function and Flexibility of the Equity Facility

Under the agreement, the company can direct Chardan to purchase newly issued shares at different points in time, and Chardan then resells those shares on the open market. Proceeds are earmarked for general corporate purposes, which may include buying more HYPE, but the language leaves room for other uses too. There’s no fixed token target or deadline attached to the facility, which gives management latitude but also means outside observers can’t predict exactly how aggressively the company will keep accumulating HYPE.

Use of Raised Capital and HYPE Token Holdings

This expanded facility builds directly on a strategy that has already reshaped Hyperliquid Strategies’ balance sheet. Before this latest amendment, the company had raised $647 million through the same equity arrangement, generated at an average issue price of $8.70 per PURR share, and used much of that capital to build one of the largest identified corporate HYPE positions.

Previous Fundraising and Token Acquisitions

Since completing its business combination in December 2025, Hyperliquid Strategies has spent $773.4 million buying approximately 16.5 million HYPE tokens, at an average price of $46.77 per token. That spending pushed the company’s total HYPE holdings from an initial 12.5 million tokens to their current size, according to its fiscal-year results. The firm also repurchased about 5.8 million of its own PURR shares for $27.8 million, at an average price of $4.80 each, putting some of the raised capital back into its own stock rather than HYPE.

Current Treasury Composition

As of Aug. 19, Hyperliquid Strategies held roughly 29.3 million HYPE tokens. The company reported $149.9 million in cash at the end of June, including $12 million in USDC, and said it carries no debt. That combination of a large token position, sizable cash reserves, and a clean balance sheet gives the company a fairly conservative financial footing even as it leans heavily on stock issuance to fund token purchases.

Regulatory Framework and Stock Market Implications

Why does the Nasdaq rule matter here? Because it sets a hard boundary on how much stock Hyperliquid Strategies can sell at low prices without asking shareholders first, and that boundary is now closer than it might seem given where the stock trades today.

Nasdaq Share Sale Cap and Stock Price Dynamics

Once total sales through the facility reach $1 billion, Nasdaq rules generally prevent the company from selling more than 42,641,847 shares below $12.02 each without shareholder approval. That share count works out to about 19.99% of shares outstanding before the amendment. Sold at $12.02 apiece, it would generate roughly $512.5 million in proceeds before fees.

Uncertainty and Market Reaction

Shares of Hyperliquid Strategies closed at $11.36 on Sept. 1, down about 7.3% for the session, trading between $11.03 and $12.31 on with trading activity reaching approximately 24.3 million shares. The final price at close falls short of the $12.02 level associated with the updated share cap, though the cap itself only applies once cumulative sales under the facility pass the $1 billion mark. In other words, the company still has some breathing room before the Nasdaq restriction becomes a practical constraint on its fundraising.

The filing does not disclose whether the company has already tapped any of the newly added $1.5 billion in capacity, nor does it report a new HYPE purchase tied to this specific amendment. That gap leaves an open question for investors watching how aggressively the company plans to keep growing its treasury.

This regulatory ceiling matters beyond the immediate mechanics of one filing. It shapes how much dilution existing shareholders could face and how quickly the company can convert its expanded equity financing capacity into actual token purchases. Selling more shares increases the total share count, which can reduce the ownership stake held by current investors, a trade-off the company appears willing to make in exchange for treasury growth.

Broader interest in Hyperliquid also colors how the market is reading this expansion. Interest in the platform increased in the previous month after President Donald Trump announced that the Commodity Futures Trading Commission was pursuing efforts to facilitate Hyperliquid into the United States under regulatory oversight. HYPE rose more than 20% following those comments, and Hyperliquid Strategies shares gained 30.4% over the same period. The company has stated it functions as an independent entity with no connection to the Hyperliquid protocol, notwithstanding the shared name and its possession of the protocol’s token, and it has noted that no CFTC application, registration, exemption, or rulemaking involving the protocol has actually been granted.

FAQ

What is the significance of expanding Hyperliquid’s equity financing facility to $2.5 billion?

It allows Hyperliquid Strategies to raise more funds over time by selling additional shares to Chardan, giving it flexibility to fund corporate needs, including acquiring more HYPE tokens, without a separate capital raise.

How has Hyperliquid Strategies used its equity facility funds so far?

Before the expansion, the company raised $647 million through the facility and spent $773.4 million acquiring about 16.5 million HYPE tokens since its business combination in December 2025.

Are there restrictions on selling shares under the expanded facility?

Yes. Nasdaq rules cap share sales below $12.02 per share without shareholder approval once cumulative sales through the facility reach $1 billion.

Has Hyperliquid Strategies used any of the newly added $1.5 billion capacity yet?

The filing does not disclose whether the company has used any portion of the newly added $1.5 billion capacity or purchased new HYPE tokens under the amended facility.

{"@context":"","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What is the significance of expanding Hyperliquid's equity financing facility to $2.5 billion?","acceptedAnswer":{"@type":"Answer","text":"It allows Hyperliquid Strategies to raise more funds over time by selling additional shares to Chardan, giving it flexibility to fund corporate needs, including acquiring more HYPE tokens, without a separate capital raise."}},{"@type":"Question","name":"How has Hyperliquid Strategies used its equity facility funds so far?","acceptedAnswer":{"@type":"Answer","text":"Before the expansion, the company raised $647 million through the facility and spent $773.4 million acquiring about 16.5 million HYPE tokens since its business combination in December 2025."}},{"@type":"Question","name":"Are there restrictions on selling shares under the expanded facility?","acceptedAnswer":{"@type":"Answer","text":"Yes. Nasdaq rules cap share sales below $12.02 per share without shareholder approval once cumulative sales through the facility reach $1 billion."}},{"@type":"Question","name":"Has Hyperliquid Strategies used any of the newly added $1.5 billion capacity yet?","acceptedAnswer":{"@type":"Answer","text":"The filing does not disclose whether the company has used any portion of the newly added $1.5 billion capacity or purchased new HYPE tokens under the amended facility."}}]}

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.